menu search

KA / Kineta to Present at Jefferies Healthcare Conference

Kineta to Present at Jefferies Healthcare Conference
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that Shawn Iadonato, Ph.D., Chief Executive Officer at Kineta, will present at the Jefferies Healthcare Conference, being held in New York, NY from June 7-9, 2023. Company management will also be available for one-on-one meetings. Read More
Posted: May 23 2023, 06:30
Author Name: GlobeNewsWire
Views: 110365

KA News  

Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023

By GlobeNewsWire
October 9, 2023

Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun more_horizontal

Kineta Announces Participation at October Investor Conferences

By GlobeNewsWire
September 28, 2023

Kineta Announces Participation at October Investor Conferences

SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal

Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

By GlobeNewsWire
September 25, 2023

Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal

Kineta to Present at Jefferies Healthcare Conference

By GlobeNewsWire
May 23, 2023

Kineta to Present at Jefferies Healthcare Conference

SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immuno more_horizontal

Kineta to Present at 22nd Annual Needham Healthcare Conference

By GlobeNewsWire
April 3, 2023

Kineta to Present at 22nd Annual Needham Healthcare Conference

SEATTLE, April 03, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal

Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023

By GlobeNewsWire
March 22, 2023

Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023

SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal


Search within

Pages Search Results: